Learning Objectives:

  1. To understand how angiogenesis and hypoxia contribute to tumor development and metastasis in

aggressive tumor types, including triple negative breast cancer

  1. To review failures of anti-hypoxia and anti-angiogenesis agents in triple negative breast cancer and

discuss the prognostic, predictive and therapeutic roles for hypoxia and angiogenesis in solid tumors

  1. To understand the importance of using patient-derived models in cancer research
Session date: 
09/28/2023 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Margarite Matossian, MD